Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2007 / Cilt: 33 - Sayı: 3

Epitheloid type renal angiomyolipoma

Epiteloid tip renal anjiyomiyolipom

Pages
357–359
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We report a multifocal epitheloid angiomyolipoma case with prominent pleomorphism and necrosis and reviewed literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Angiomyolipoma (AML) is a well-known rare soft tissue tumor involving the kidneys, liver and other organs.
📊
Key Findings & Data:Immunreactivity with HMB45 and CD68 are helpful for its identification.
💡
Conclusion & Impact:We report a multifocal epitheloid angiomyolipoma case with prominent pleomorphism and necrosis and reviewed literature.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Anjiomiyolipom · Nefrektomi · Neoplazmlar

Abstract

Introduction: Angiomyolipoma (AML) is a well-known rare soft tissue tumor involving the kidneys, liver and other organs. For a long time believed to be a benign hamartoma, angiomyolipoma is now considered a neoplasm that arises from perivascular epitheloid cell. Epitheloid angiomyolipoma is a rare variant of angiomyolipoma characterized by epitheloid cells that mimic renal cell carcinoma and it is potentially malignant. Immunreactivity with HMB45 and CD68 are helpful for its identification. We report a multifocal epitheloid angiomyolipoma case with prominent pleomorphism and necrosis and reviewed literature.

Özet

Anjiyomiyolipom (AML) böbrek, karaciğer ve diğer organları tutabilen ender görülen ve iyi bilinen bir yumuşak doku tümörüdür. Yıllar boyunca benin hamartom olarak kabul edilmiştir fakat günümüzde perivasküler epiteloid hücrelerden kaynaklanan bir neoplasm olarak kabul edilir. Epiteloid anjiyomiyolipom, böbrek hücreli kanseri taklit eden ve malin potansiyeli olan epiteloid hücreler ile karakterize anjiyomiyolipomun ender bir çeşididir. HMB45 ve CD68 immünreaktivitesi tanıda yardımcıdır. Bu makalede yoğun pleomorfizm ve nekroz gösteren multifokal epiteloid tip AML olgusu sunup ilgili yayınları gözden geçirdik.

🔖

Cite This Article

FAYDACI, G., URUÇ, F., MURTAZAOĞLU, M., TARHAN, F., ERYILDIRIM, B., KUYUMCUOĞLU, U. (2007). Epitheloid type renal angiomyolipoma. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 33 - Sayı: 3, 357–359. https://ajindex.com/articles/328300

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Murphy WM, Beckwith JB, Farrow GM: Angiomyolipoa. Atlas of Tumor Pathology: Tumors of the Kidney, Bladder, and 'Related Urinary Structures. Washington DC: Armed Forces Institute of Pathology; 161-174, 1993
  2. Ashfaq R, Weinberg AG, Albores-Saavedra J: Renal angiomyolipomas and HMB-45 reactivity. Cancer.; 71: 3091-7, 1993
  3. Pea M, Bonetti F, Martignoni G, Henske EP, Manfrin E, Colato C, Bernstein J: Apparent renal cell carcinomas in tuberous sclerosis are heterogeneous: The identification of malignant epithelioid angiomyolipoma. Am J Surg Pathol; 22: 180-7, 1998
  4. Christiano AP, Yang X, Gerber GS: Malignant transformation of renal angiomyolipoma. J Urol.; 161: 1900-1,1999
  5. Bosniak MA, Megibow AJ, Hulnick DH: CT diagnosis of renal angiomyolipoma: The importance of detecting small amounts of fat. AJR Am J Roentgenol; 151: 497- 501,1998
  6. Eble JN, Amin MB, Young RH: Epithelioid angiomyolipoma of the kidney: A report of five cases with a prominent and diagnostically confusing epithelioid smooth muscle component. Am J Surg Path; 21: 1123-30, 1997
  7. Mai KT, Perkins DG, Collins JP: Epithelioid cell variant of renal angiomyolipoma. Histopathology.; 28: 277- 80, 1996
  8. Bjornsson J, Short MP, Kwiatkowski DJ, Henske EP: Tuberous sclerosis-associated renal cell carcinoma. Clinical, pathological, and genetic features. Am J Pathol.; 149: 1201-8, 1996
  9. Açıkahn MF, Tel N, Öner U, Paşaoğlu O, Dönmez T: Epithelioid angiomyolipoma of the kidney. Int J Urol.; 12:204-7,2005.